Last month was a busy one for pharmas in acquiring delivery technology developers. AstraZeneca completed the acquisition of pulmonary delivery company, Pearl Therapeutics, by acquiring 100% of its shares...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)